Nature Medicine
2026-06-24 00:00
DOI:
HASH:8ced04b4d4cf9058f0ad37dd5ac1fa5a
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
Authors:
Abstract
No abstract for this item (typically a correction, editorial or news piece — the publisher provides none)